BMC Ophthalmology · 2006 · 15 citations · 6 references
PharmacyOphthalmologySurgeryOcular Drug DeliveryOphthalmic Drug DeliveryOphthalmic SurgeryAnterior Segment Drug DeliveryCorneal Drug DeliveryMydriatic AgentsOphthalmic FormulationsTopical Ocular Drug DeliveryTopical Ophthalmic MedicationsDepot EffectDrug Delivery To The EyePhenylephrine AdministrationPupil DiameterSafe SurgerySingle-blind TrialsTherapeutic Pupil DilationTopical Mydriatic Agents
BACKGROUND: A prerequisite for safe cataract surgery is an adequately dilated pupil. The authors conducted a trial to assess the efficacy (in terms of pupil diameter) of a depot method of pre-operative pupil dilatation, as compared with repeated instillations of drops (which is time-consuming for the nursing staff and uncomfortable for the patient). METHODS: A prospective randomised masked trial was conducted comprising 130 patients with no significant ocular history undergoing elective clear corneal phacoemulsification. 65 patients had mydriatic drops (Tropicamide 1%, Phenylephrine 2.5%, Diclofenac sodium 0.1%) instilled prior to surgery, 65 had a wick soaked in the same drop mixture placed in the inferior fornix. Horizontal pupil diameters were recorded on a millimetre scale immediately prior to surgery. RESULTS: There was no significant difference in pupil size between the two groups (p = 0.255, Student's t-test). CONCLUSION: There was no significant difference between the mydriasis obtained with the depot system compared with conventional drop application. Use of a depot mydriatic delivery system appears to be a safe and efficient method of drug delivery. TRIAL REGISTRATION: International Standard Randomised Controlled Trial Number Register ISRCTN78047760.
6
John G Lawrenson, David F. Edgar, A C Gudgeon et al. · British Journal of Ophthalmology · 1993 · 20 citations · Full text